Fierce Pharma
DECEMBER 22, 2023
Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise. | Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise.
Dominic Tyer
DECEMBER 22, 2023
Traditionally R&D’s province, the meteoric rise of AI has turbo-charged discussions about how commercial organisations can make use of artificial intelligence.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
DECEMBER 22, 2023
As the FDA investigates a safety signal for approved CAR-T therapies, the agency has upgraded a warning about secondary cancers resulting from use of Johnson & Johnson and Legend Biotech’s Carv | As the FDA investigates a safety signal for approved CAR-T therapies, the agency has elevated a warning about secondary cancers resulting from use of Johnson & Johnson and Legend Biotech’s Carvykti.
European Pharmaceutical Review
DECEMBER 22, 2023
French pharmaceutical giant Sanofi announced that it is ending the development programme evaluating tusamitamab ravtansine as a monotherapy for certain patients with metastatic non-squamous, non-small cell lung cancer (NSCLC). The decision comes after interim analysis from a Phase III clinical trial , CARMEN-LC03, did not meet a primary end point. CARMEN-LC03, a randomised, open-label study was evaluating tusamitamab ravtansine as monotherapy compared to docetaxel in patients with metastatic non
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
DECEMBER 22, 2023
The FDA and Novo Nordisk are warning of c | The FDA and Novo Nordisk are warning of counterfeit versions of popular weight-loss treatment Ozempic that have been discovered in the “legitimate” United States supply chain.
MedCity News
DECEMBER 22, 2023
In a recent webinar, Dr. Christopher Newman of Mary Washington Healthcare discussed how utilizing the principles of informed awareness has transformed staff experience and facilitated a more productive, efficient, and engaged workforce.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
DECEMBER 22, 2023
Some healthcare organizations have reduced health equity to a buzzword, using the phrase superficially without a true commitment to dismantling systemic barriers. During a webinar, two industry leaders — AMA President Jesse Ehrenfeld and Emory Healthcare Chief Transformation Officer Amaka Eneanya — discussed why this approach must be avoided and explored how leaders can do better.
PharmExec
DECEMBER 22, 2023
Oxford Academic report explores the positive improvements these technological capabilities could bring to the industry.
MedCity News
DECEMBER 22, 2023
Health equity is not an abstract concept but a tangible goal that can be achieved through a deliberate and comprehensive approach. By focusing on the pillars of awareness and education, equal access to care, advocacy, and technology can begin to close the healthcare disparities gap.
European Pharmaceutical Review
DECEMBER 22, 2023
Bristol Myers Squibb (BMS) has agreed to acquire Karuna Therapeutics for a total of $14.0 billion, strengthening its neuroscience portfolio. Under the terms of the deal, BMS will acquire all outstanding shares of Karuna Therapeutics common stock for $330.00 per share in cash. This represents a 53 percent premium on Karuna’s closing stock price on 21 December 2023.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
DECEMBER 22, 2023
This year brought about a whole gambit of news and developments, of conferences and launches, all coming in thick and fast and excited about the pharmaceutical industry and healthcare system. Not least of these was Smith + Nephew’s opening of a new state-of-the-art surgical innovation and training centre in the heart of Munich, Germany, on 11th October.
European Pharmaceutical Review
DECEMBER 22, 2023
MeiraGTx has entered into an asset purchase agreement with Janssen Pharmaceuticals for the remaining interests in botaretigene sparoparvovec (bota-vec) a gene therapy for the treatment of X-linked retinitis pigmentosa (XLRP). Under the agreement, MeiraGTx is to receive $130 million in upfront and near-term milestone payments. The company will receive up to an additional $285 million in cash payments upon first commercial sales of bota-vec in the US and EU, as well as for manufacturing technology
Pharmaceutical Technology
DECEMBER 22, 2023
As the number of patients with cancers continues to grow globally, research into personalised cancer vaccines is vital.
pharmaphorum
DECEMBER 22, 2023
AstraZeneca and Ionis get first approval for ATTR polyneuropathy drug Wainua (eplontersen), a rival to drugs from Alnylam and Pfizer
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
eMediWrite
DECEMBER 22, 2023
Every year, pharma marketing teams engage in multi-phased, cross-functional, multi-organizational strategic planning and also in aligning work-stream dubbed “Brand Planning” by many in the industry. Brand planning is often a three-phased process that includes Strategic Planning, Tactical Planning, and Budget Planning. Every quarter, marketing teams (Consumer, HCP, and Payer) align on the brand’s mission, strategic imperatives, and high-level programs.
Rep-Lite
DECEMBER 22, 2023
In today’s competitive healthcare landscape, the role of medical staffing agencies stands as a critical force in sourcing and securing top-tier talent for crucial roles such as healthcare and medical sales representatives, along with medical device specialists. These agencies serve as integral partners in the talent acquisition process, offering specialized expertise and resources that streamline recruitment and elevate the quality of healthcare professionals entering the field.
Pharmaceutical Technology
DECEMBER 22, 2023
Improve Vision with Implantable Corneal and Intraocular Implants - Patent Granted to Bausch Health Companies Inc. Discover a method for clear visualization of the eye using a photochromic polymer mask and controlled external stimuli.
Pharmaceutical Commerce
DECEMBER 22, 2023
Camille Lee discusses the impact of commercial availability of Bimzelx for the treatment of moderate-to-severe plaque psoriasis in adults, along with the value of patient assistance/affordability programs.
Zymewire
DECEMBER 22, 2023
As we all unwind for the holidays, we’re taking a break from the realm of prospecting in biopharma to highlight a group of folks who have woven the spirit of giving into the fabric of clinical research. Founded with a profound purpose – to elevate awareness, foster trust, and extend the gift of health to those in need – Greater Gift stands as a beacon of appreciation for unsung heroes of clinical trials.
Pharmaceutical Technology
DECEMBER 22, 2023
Angelini Spa has filed a patent for a method and apparatus to produce fluff-free absorbent cores for sanitary articles. Discover how loose fibers and superabsorbent granular material are mixed and bound together to create an absorbent structure.
Pharmacy Times
DECEMBER 22, 2023
The drug is the first medicine to be approved for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis that can be self-administered.
PharmaVoice
DECEMBER 22, 2023
A presidential candidate, a changing biotech market and an enduring murder mystery — here are PharmaVoice’s most-read articles this year.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmaceutical Technology
DECEMBER 22, 2023
The US FDA has granted breakthrough therapy designation for BioNTech and DualityBio's BNT323/DB-1303 to treat advanced endometrial cancer.
Pharmacy Times
DECEMBER 22, 2023
In a study, most patients had specified SBP targets of less than 160 mmHg and all patients attained goal within a relatively short period of time.
Pharmaceutical Technology
DECEMBER 22, 2023
The China NMPA approved Takeda’s Livtencity to treat adults with post-HSCT or solid organ transplant cytomegalovirus infection/disease.
Pharmacy Times
DECEMBER 22, 2023
The investigators note that psilocybin’s effectiveness in treating depressive symptoms and the positive reception among patients with cancer are encouraging continued research.
Pharmaceutical Technology
DECEMBER 22, 2023
ImmunoScape has signed a collaboration with EDDC to develop new T cell receptor (TCR)-based bispecific molecules for solid tumours.
Pharmacy Times
DECEMBER 22, 2023
Families that reported a lower income before the pandemic were more likely to experience hardships if headed by an adult with COVID-19 illness.
Pharmaceutical Technology
DECEMBER 22, 2023
Ono has signed an agreement with EVQLV to utilise its AI-powered antibody design engine for the development of new antibody drugs.
Pharmacy Times
DECEMBER 22, 2023
This latest revision introduces a new set of drug criteria, refines the existing ones, and enhances the overall formatting to ensure increased ease of use and clarity for its recommendations.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
348 
Let's personalize your content